对于长期太空任务的药理应对措施:解决心血管挑战和推进适应太空的医疗保健
Audrey Derobertmasure1, Li Shean Toh2, Virginia E Wotring3
1Faculty of Medicine, Paris Cité University, INSERM PARCC, Service de Pharmacologie Clinique, Hôpital Européen Georges Pompidou Hospital (AP-HP), Paris, France.
概括
开发有效的药理对策对于长期太空任务至关重要. 这项研究解决了太空飞行药理学方面的挑战,重点是个性化医学和宇航员医疗保健的创新技术.
科学领域:
- 太空医学 太空医学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 低地球轨道 (LEO) 以外的长期太空任务给宇航员带来了重大的医疗保健挑战.
- 药理对策对于减轻太空飞行期间的健康风险至关重要.
- 目前的战略需要适应太空飞行的独特条件,包括道德和监管方面.
研究的目的:
- 以心血管系统为模型,突出太空任务的药理学对策的当前挑战.
- 提出创新策略,以适应制药方法进行太空飞行.
- 为太空探险者提供安全有效的药物护理.
主要方法:
- 审查欧洲航天局 (ESA) 的SciSpacE药理对策路线图.药理对策.
- 专注于心血管系统,以说明所识别的挑战的潜在影响.
- 探索先进技术:药物基因组学,治疗药物监测,微量采样和药物监测.
主要成果:
- 确定了适应药物管理,储存和稳定性用于太空飞行的挑战.
- 拟议整合生物标志物 (药物基因组学) 和治疗药物监测,以实现个性化剂量.
- 突出了先进技术的潜力,如有机体,人工智能和机器学习,用于太空中的PK/PD建模.
结论:
- 创新的制药工具和个性化治疗对于未来太空任务中的宇航员健康至关重要.
- 战略包括先进的药物监测,太空制造和人工智能和生物银行的整合.
- 太空飞行药理学的发展将为地球上的医疗保健带来互惠的好处.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
Antianginal Drugs: Nitrates and β-Blockers
486
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
486
Heart Failure Drugs: β-Blockers
303
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
303
Heart Failure Drugs: Inotropic Agents
488
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
488
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
38
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
38


